| Not Yet Recruiting | A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment o Advanced Pancreatic Cancer | Phase 3 | 2026-01-01 |
| Recruiting | A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recur Recurrent or Metastatic Nasopharyngeal Carcinoma | Phase 3 | 2025-05-06 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Car Recurrent or Metastatic Nasopharyngeal Carcinoma | Phase 2 | 2023-04-06 |
| Recruiting | A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Advanced or Metastatic Urothelium Cancer | Phase 3 | 2023-04-06 |
| Unknown | A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN Squamous Cell Carcinoma of the Head and Neck | Phase 3 | 2023-03-01 |
| Unknown | A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors. Advanced Malignant Solid Tumors | Phase 1 / Phase 2 | 2022-08-05 |
| Unknown | A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2022-06-30 |
| Unknown | A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer Patients Breast Cancer With Liver Metastases | Phase 2 | 2022-03-23 |
| Unknown | A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesop Locally Advanced Gastric Cancer, Metastatic HER2 Positive Gastroesophageal Junction Cancer | Phase 2 | 2022-01-19 |
| Unknown | A Study of MRG002 in the Treatment of Patients With HER2-mutated Unresectable/Metastatic Non-small Cell Lung C Non-small- Cell Lung Cancer (NSCLC) | Phase 2 | 2021-12-01 |
| Unknown | A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors Advanced or Metastatic Solid Tumors | Phase 1 / Phase 2 | 2021-07-26 |
| Unknown | A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Advanced Breast Cancer, Metastatic Breast Cancer | Phase 2 / Phase 3 | 2021-06-30 |
| Unknown | A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Advanced or Metastatic Biliary Tract Cancer | Phase 2 | 2021-06-07 |
| Unknown | A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Advanced Gastric Cancer. Advanced or Metastatic Gastric Cancer, Advanced or Metastatic Gastroesophageal Junction Carcinoma | Phase 2 | 2021-05-24 |
| Active Not Recruiting | A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gast Advanced Solid Tumors, Advanced or Metastatic Gastric Cancer, Advanced or Metastatic Gastroesophageal Junction Cancer | Phase 1 / Phase 2 | 2021-05-24 |
| Unknown | A Study of MRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC) Advanced or Metastatic Breast Cancer | Phase 2 | 2021-05-13 |
| Unknown | A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Advanced or Metastatic Biliary Tract Cancer | Phase 2 | 2021-04-28 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent or Metastatic Squamous Cell C Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck | Phase 2 | 2021-04-23 |
| Unknown | A Study of MRG002 in the Treatment of HER2-positive Unresectable Locally Advanced or Metastatic Urothelium Can Locally Advanced Urothelial Cancer, Metastatic Urothelial Carcinoma | Phase 2 | 2021-04-20 |
| Unknown | A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell L Carcinoma, Non-Small-Cell Lung | Phase 2 | 2020-09-04 |
| Unknown | Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL) Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL) | Phase 1 | 2019-06-25 |
| Unknown | A Study of MRG002 in the Treatment of Patients With HER2-positive Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2018-11-21 |
| Completed | A Study of MRG003 in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2018-05-09 |